Given the zoonotic potential of a MAC infected dog particularly to immunocompromised human patients, diseased dogs pose a public health risk. While not a reportable disease, treatment of systemic mycobacteriosis is generally not effective and discouraged in dogs. The collaborative efforts by microbiologists, veterinary clinicians, dog breeders, primary care physicians, and infectious disease specialists applying the One Health approach is therefore crucial for the best management and prevention of MAC infection.
Keyphrases
- primary care
- health risk
- infectious diseases
- healthcare
- end stage renal disease
- ejection fraction
- endothelial cells
- mental health
- public health
- newly diagnosed
- chronic kidney disease
- heavy metals
- mycobacterium tuberculosis
- palliative care
- risk assessment
- human health
- patient reported outcomes
- climate change
- general practice
- pluripotent stem cells